Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.

Clinical trial NCT03219970 · COMPLETED

Trial details

NCT number: NCT03219970
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2017-09-05
Primary completion: 2020-10-28
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.